A carregar...
DE-ESCALATING TREATMENT FOR HER2-POSITIVE EARLY BREAST CANCER
HER2-positive breast cancers are defined by amplification of the cerbB2 gene and overexpression of its protein HER2. This subtype of breast cancer is aggressive, grows rapidly, and metastasizes early. However, new treatments targeting HER2 combined with chemotherapy have dramatically altered the cou...
Na minha lista:
| Publicado no: | Trans Am Clin Climatol Assoc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Clinical and Climatological Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7358497/ https://ncbi.nlm.nih.gov/pubmed/32675852 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|